- Home
- MEI vs NMRA Comparison
MEI vs NMRA Comparison
Compare MEI & NMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MEI
- NMRA
- Stock Information
- Founded
- MEI 1946
- NMRA 2019
- Country
- MEI United States
- NMRA United States
- Employees
- MEI N/A
- NMRA N/A
- Industry
- MEI Electrical Products
- NMRA
- Sector
- MEI Technology
- NMRA
- Exchange
- MEI Nasdaq
- NMRA Nasdaq
- Market Cap
- MEI 286.7M
- NMRA 268.5M
- IPO Year
- MEI N/A
- NMRA 2023
- Fundamental
- Price
- MEI $8.11
- NMRA $1.45
- Analyst Decision
- MEI Buy
- NMRA Hold
- Analyst Count
- MEI 2
- NMRA 8
- Target Price
- MEI $11.25
- NMRA $5.83
- AVG Volume (30 Days)
- MEI 466.9K
- NMRA 376.8K
- Earning Date
- MEI 09-09-2025
- NMRA 11-11-2025
- Dividend Yield
- MEI 3.46%
- NMRA N/A
- EPS Growth
- MEI N/A
- NMRA N/A
- EPS
- MEI N/A
- NMRA N/A
- Revenue
- MEI $1,030,100,000.00
- NMRA N/A
- Revenue This Year
- MEI N/A
- NMRA N/A
- Revenue Next Year
- MEI $3.55
- NMRA N/A
- P/E Ratio
- MEI N/A
- NMRA N/A
- Revenue Growth
- MEI N/A
- NMRA N/A
- 52 Week Low
- MEI $5.08
- NMRA $0.61
- 52 Week High
- MEI $17.45
- NMRA $17.19
- Technical
- Relative Strength Index (RSI)
- MEI 61.80
- NMRA 36.91
- Support Level
- MEI $7.87
- NMRA $1.48
- Resistance Level
- MEI $8.73
- NMRA $1.70
- Average True Range (ATR)
- MEI 0.37
- NMRA 0.10
- MACD
- MEI 0.06
- NMRA -0.03
- Stochastic Oscillator
- MEI 71.33
- NMRA 7.21
About MEI Methode Electronics Inc.
Methode Electronics Inc supplier of custom-engineered solutions with sales, engineering, and manufacturing locations in North America, Europe, the Middle East, and Asia. It designs, engineers, and produces mechatronic products for Original Equipment Manufacturers (OEMs) utilizing a broad range of technologies for user interface, light-emitting diode (LED) lighting systems, power distribution, and sensor applications. The firm is organized into various business segments: Automotive, Industrial, Interface, and Medical. The Automotive segment, which generates maximum revenue, supplies electronic and electro-mechanical devices and related products to automobiles, including overhead and center consoles, hidden and ergonomic switches, insert molded components, LED-based lighting, and sensors.
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.